These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 23991511)
1. Omega-3 fatty acids and cardiovascular risk. Kruse LG; Ogletree RL J Miss State Med Assoc; 2013 Jun; 54(6):156-7. PubMed ID: 23991511 [TBL] [Abstract][Full Text] [Related]
2. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Kwak SM; Myung SK; Lee YJ; Seo HG; Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407 [TBL] [Abstract][Full Text] [Related]
4. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. Casula M; Soranna D; Catapano AL; Corrao G Atheroscler Suppl; 2013 Aug; 14(2):243-51. PubMed ID: 23958480 [TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials. Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581 [TBL] [Abstract][Full Text] [Related]
6. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):808-18. PubMed ID: 23110790 [TBL] [Abstract][Full Text] [Related]
7. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis. Yan J; Liu M; Yang D; Zhang Y; An F Cardiovasc Drugs Ther; 2024 Aug; 38(4):799-817. PubMed ID: 36103100 [TBL] [Abstract][Full Text] [Related]
9. Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease? Rizos EC; Elisaf MS Curr Cardiol Rep; 2017 Jun; 19(6):47. PubMed ID: 28432658 [TBL] [Abstract][Full Text] [Related]
10. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials. Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469 [TBL] [Abstract][Full Text] [Related]
12. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials. Chen Q; Cheng LQ; Xiao TH; Zhang YX; Zhu M; Zhang R; Li K; Wang Y; Li Y Cardiovasc Drugs Ther; 2011 Jun; 25(3):259-65. PubMed ID: 21626218 [TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Jaca A; Durão S; Harbron J S Afr Med J; 2020 Nov; 110(12):1158-1159. PubMed ID: 33403957 [TBL] [Abstract][Full Text] [Related]
14. The role of omega-3 polyunsaturated fatty acids in cardiovascular health. Barrett SJ Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids supplementation on major cardiovascular outcomes: an umbrella review of meta-analyses of observational studies and randomized controlled trials. Choi H; Kim JY; Lee KH; Kim JS; Lee JY; Choi EK; Seong HJ; Kim G; Park H; Jung E; Hong SH; Kronbichler A; Eisenhut M; Koyanagi A; Jacob L; Yon DK; Lee SW; Kim MS; Kostev K; Shin JI; Yang JW; Smith L Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2079-2092. PubMed ID: 33660821 [TBL] [Abstract][Full Text] [Related]
16. Omega-3 Fatty Acids and Primary and Secondary Prevention of Cardiovascular Disease. Cao Y; Lu L; Liang J; Liu M; Li X; Sun R; Zheng Y; Zhang P Cell Biochem Biophys; 2015 May; 72(1):77-81. PubMed ID: 25427890 [TBL] [Abstract][Full Text] [Related]
17. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention. Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253 [TBL] [Abstract][Full Text] [Related]
18. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908 [TBL] [Abstract][Full Text] [Related]
19. Effects of Omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Wen YT; Dai JH; Gao Q Nutr Metab Cardiovasc Dis; 2014 May; 24(5):470-5. PubMed ID: 24472636 [TBL] [Abstract][Full Text] [Related]
20. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Hooper L; Thompson RL; Harrison RA; Summerbell CD; Moore H; Worthington HV; Durrington PN; Ness AR; Capps NE; Davey Smith G; Riemersma RA; Ebrahim SB Cochrane Database Syst Rev; 2004 Oct; (4):CD003177. PubMed ID: 15495044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]